0001193125-24-143664.txt : 20240521 0001193125-24-143664.hdr.sgml : 20240521 20240521115650 ACCESSION NUMBER: 0001193125-24-143664 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 EFFECTIVENESS DATE: 20240521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N CENTRAL INDEX KEY: 0000813572 ORGANIZATION NAME: IRS NUMBER: 232030787 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-100567 FILM NUMBER: 24967958 BUSINESS ADDRESS: STREET 1: 200 BLOOR STREET EAST ST 10 STREET 2: TORONTO M4W 1EF CITY: ONTARIO CANADA STATE: A6 ZIP: 48304 BUSINESS PHONE: 4169266302 MAIL ADDRESS: STREET 1: P O BOX 600 CITY: BUFFALO STATE: NY ZIP: 14201-0600 FORMER COMPANY: FORMER CONFORMED NAME: MANUFACTURERS LIFE INS CO USA SEPARATE ACCOUNT N DATE OF NAME CHANGE: 20020411 FORMER COMPANY: FORMER CONFORMED NAME: SEPARATE ACCOUNT FOUR OF THE MANUFACTURERS LIFE INS CO OF AM DATE OF NAME CHANGE: 19920703 0000813572 S000009940 JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N C000027518 Corporate VUL 03 C000027519 Corporate VUL 04 497 1 d799860d497.htm JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

SEPARATE ACCOUNTS A AND N

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

SEPARATE ACCOUNT B

Supplement dated May 21, 2024 to the Statutory Prospectuses,

Updating Summary Prospectuses, and Initial Summary Prospectuses,

dated April 29, 2024

Changes to Variable Investment Options

This Supplement is intended for distribution with the Statutory Prospectuses, Updating Summary Prospectuses, and Initial Summary Prospectuses, as applicable, (each a “prospectus”) dated April 29, 2024 for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable. The affected prospectuses belong to the following policies:

 

   
Corporate VUL 03    Survivorship VUL
   
Corporate VUL 04    VUL Accumulator
   
EPVUL    VUL Protector
   
SPVL     


Portfolio Name Change and Subadviser Change

Effective on or about May 29, 2024 (the “Effective Date”), the Emerging Markets Value Trust will be renamed as listed below:

 

Former Name    New Name
Emerging Markets Value Trust    Disciplined Value Emerging Markets Equity Trust

On or about the Effective Date, the renamed portfolio’s subadvisor will be replaced as indicated below:

 

Former Subadviser    New Subadviser
Dimensional Fund Advisors LP    Boston Partners Global Investors, Inc.

As a result, after the Effective Date, all references in the prospectuses to the Former Name and Former Subadviser are changed to the New Name and New Subadviser, respectively.

Changes to Current Expenses

On or about the Effective Date, there is a reduction in “Current Expenses” for the JHVIT Disciplined Value Emerging Markets Equity Trust in the “Appendix: Portfolios Available Under the Contract” section of the prospectus.

Accordingly, the name, subadviser, and “Current Expenses” of the JHVIT Emerging Markets Value Trust Series I portfolio are deleted in the “Appendix: Portfolios Available Under the Contract” section of each prospectus and replaced with the following:

 

Investment Objective    Portfolio and Adviser/Subadviser    Current
Expenses
   

Average Annual Total
Returns

(as of 12/31/23) (%)

 
  1-Year      5-Year      10-Year  

To seek long-term capital appreciation.

  

Disciplined Value Emerging Markets

Equity Trust – Series I

John Hancock Variable Trust Advisers

LLC/Boston Partners Global Investors, Inc.

     1.01 %*      15.19        5.38        3.01  

 

*

This portfolio’s annual expenses reflect temporary fee or expense waivers or reimbursements.

 

 

You should read this supplement together with the prospectus for the contract you purchased and retain both documents for future reference.

Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.


VLI ProdSupp VL 05/2024

 

333-85284    333-71136    333-85296    333-33504    333-100567
333-88748    333-100597    333-88972    333-100664